Thomas J. Duszynski

Population Point Prevalence of SARS-CoV-2 Infection Based on a Statewide Random Sample — Indiana, April 25–29, 2020

Nir Menachemi, Constantin T. Yiannoutsos, Brian E. Dixon et al. · MMWR Morbidity and Mortality Weekly Report · 2020 · 198 citations · Full text

Public Health, Infectious Diseases, Population Health Sciences +8

Interim Effectiveness of Updated 2023–2024 (Monovalent XBB.1.5) COVID-19 Vaccines Against COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalization Among Immunocompetent Adults Aged ≥18 Years — VISION and IVY Networks, September 2023–January 2024

Jennifer DeCuir, Amanda B. Payne, Wesley H. Self et al. · MMWR Morbidity and Mortality Weekly Report · 2024 · 77 citations · Full text

Veterinary Medicine, Infectious Diseases, Preventive Medicine +17

Interim Estimates of 2024–2025 COVID-19 Vaccine Effectiveness Among Adults Aged ≥18 Years — VISION and IVY Networks, September 2024–January 2025

Ruth Link‐Gelles, Sean Chickery, A Webber et al. · MMWR Morbidity and Mortality Weekly Report · 2025 · 77 citations · Full text

Veterinary Medicine, Infectious Diseases, Preventive Medicine +17

Symptoms and symptom clusters associated with SARS-CoV-2 infection in community-based populations: Results from a statewide epidemiological study

Brian E. Dixon, Kara Wools‐Kaloustian, William F. Fadel et al. · PLoS ONE · 2021 · 76 citations · Full text

Public Health, Community Health, Infectious Diseases +15

Symptoms and symptom clusters associated with SARS-CoV-2 infection in community-based populations: Results from a statewide epidemiological study

Brian E. Dixon, Kara Wools‐Kaloustian, William F. Fadel et al. · medRxiv · 2020 · 41 citations · Full text

Public Health, Community Health, Infectious Diseases +15